#Canada #Toronto #Xtalks #BioAgilytix #Assay Cross-Validation

Join the Upcoming Webinar on Assay Cross-Validation Strategies

In today's globalized landscape of drug development, maintaining the integrity of bioanalytical assays is paramount. This upcoming free webinar titled Strategies to Reduce Risk in Multi-Site Assay Cross-Validation will provide invaluable insights into assay transfer best practices. Hosted by Xtalks, this event is designed for professionals in the pharmaceutical, biotech, and healthcare sectors seeking to enhance their understanding of cross-validation processes across diverse laboratory locations.

Understanding the Importance of Cross-Validation

As bioanalytical methods are increasingly utilized for pharmacokinetic assessments, immunogenicity evaluations, and biomarker determinations, establishing consistency among laboratories is crucial. The webinar will address the importance of inter-laboratory concordance, particularly for regulatory submissions, ensuring that data adheres to current regulatory expectations.

Key Features of the Webinar

Attendees can look forward to learning how to:

• - Develop aligned protocols for assay transfer
• - Utilize suitable reagents and instrumentation to ensure reliable results
• - Implement strategic approaches for demonstrating assay concordance among sites

Featured speakers include leading experts from BioAgilytix, such as Dr. Lynn Kamen, who serves as Executive Director of the Scientific Office, and Jessica Weaver, Associate Director of Scientific Affairs. These industry veterans will share their knowledge on utilizing reference standards and quality controls, as well as real-world samples, to assess performance across different sites.

Strategies to Enhance Assay Reliability

The webinar will delve into practical strategies that can be employed to minimize variations arising from site-specific reagent lots, instrumentation discrepancies, or analyst interpretation biases. By focusing on structured assay transfer protocols and robust statistical methodologies, participants will gain insights into:

• - Bias assessment techniques
• - Equivalence testing approaches that identify inter-site discordance

These methods will be emphasized as key tools for ensuring assay reliability and precision across multi-site drug development programs.

Webinar Details

The live session will take place on Monday, July 20, 2026, at 10am EDT (4pm CEST/EU-Central). This is an excellent opportunity for professionals to gain firsthand knowledge on effective risk reduction strategies in multi-site assay validation and enhance their company's scientific capabilities.

About Xtalks

Xtalks serves the Life Science Community by delivering trusted knowledge and collaborative insights across the pharmaceutical, biotech, medtech, and healthcare sectors. Through features such as webinars, news articles, expert interviews, and curated job opportunities, Xtalks fosters an environment of informed decision-making among industry professionals.

For more information about the webinar or to register, please visit the Xtalks website. Ensuring robust data quality and regulatory compliance is essential in the evolving world of drug development, and this webinar aims to equip attendees with the tools necessary for success!

Conclusion

Don’t miss the chance to learn from experts who are shaping the future of bioanalytical science. Register today and join the conversation on advancing multi-site assay cross-validation strategies, aligning them with best practices to innovate and excel in today's competitive market.